Ivosidenib (AG-120) induced durable remissions and transfusion independence in patients with IDH1-mutant relapsed or refractory myelodysplastic syndrome: Results from a phase 1 dose escalation and expansion study Meeting Abstract
| Authors: | DiNardo, C. D.; Watts, J. M.; Stein, E. M.; de Botton, S.; Fathi, A. T.; Prince, G. T.; Stein, A. S.; Foran, J. M.; Stone, R. M.; Patel, P. A.; Tallman, M. S.; Choe, S.; Wang, H.; Zhang, V.; Dai, D.; Fan, B.; Yen, K. E.; Kapsalis, S. M.; Hickman, D.; Agresta, S. V.; Liu, H.; Wu, B.; Attar, E. C.; Kantarjian, H. M. |
| Abstract Title: | Ivosidenib (AG-120) induced durable remissions and transfusion independence in patients with IDH1-mutant relapsed or refractory myelodysplastic syndrome: Results from a phase 1 dose escalation and expansion study |
| Meeting Title: | 60th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 132 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2018 Dec 1-4 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2018-11-29 |
| Language: | English |
| ACCESSION: | WOS:000454837605169 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood-2018-99-111264 |
| Notes: | Meeting Abstract: 1812 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work